Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease

Recruitment Information:

Seeking volunteers with following diagnosis: PD Study Type: Interventional
Eligible Ages: 18 - 100 Status: Recruiting
Time Since Diagnosis: Any may be eligible Study Focus: Neuroprotection

Study Purpose:

A multicentre, parallel-group, randomized, placebo-controlled european study. This trial aims to assess that deferiprone (study drug), which is an iron trapping treatment, might slow the progression of Parkinson’s disease, and that this drug is well tolerated.

Find a Site Location and Contact the Trial Team

More Details

Phase: Phase 2/Phase 3 Lead Sponsor: CHRU of Lille, FRANCE
Trial ID: 004322 Sponsor Type: Industry
Primary Country: France Additional Collaborators or Sponsors:
Estimated Enrollment: 338 Study Start Date: February 2016
Estimated Study Completion Date: Source:
Study Website: fairpark2.eu/

More Inclusion & Exclusion Criteria

Share This Trial

Fox Trial Finder strives to make all trial postings as accurate and complete as possible. If you believe any of the information on this page is not accurate, click here to contact us. Thank you for your support.

Choose your location

Please select a Trial Location.


You have favorited this trial!

This trial will be listed in the "Favorites" category of your dashboard.


You are not interested.

This trial will be listed in the "Not Interested" category on your dashboard. You can click "Interested" if you change your mind.

Message to Trial Coordinator

Your message was sent.

Your message was sent to the trial team at the location you selected. Check your dashboard for a response.

Login to Fox Trial Finder

Please enter your email address and password to access your My Fox Trial Finder dashboard.

*indicates required field.

Contact Fox Trial Finder

What best describes you?

*indicates required field.